4th Quarter - Termination

TODD STRATEGY GROUP for CELGENE CORPORATION

Firm
Client
Income
$50,000
Expenses
—
Terminated
Dec 31, 2019

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 21, 2020 $50,000 Replaced
4th Quarter - Termination (this page) Apr 17, 2020 $50,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

User Fee Agreement Reauthorization.

LobbyistCovered position, as disclosed
PAUL EDATTEL —
DANIEL M TODD —

Contacted: Office of Management & Budget (OMB); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

General Medicare/Medicaid Issues. Medicare reimbursement for transformative therapies. CREATES Act and FDA REMS reform. President's American Patients First Blueprint.

LobbyistCovered position, as disclosed
PAUL EDATTEL Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg
DANIEL M TODD Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid

Contacted: SENATE; Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.